AcelRx Pharmaceuticals Inc expected to post a loss of 7 cents a share - Earnings Preview

Talphera

12/11/2021 16:03

* AcelRx Pharmaceuticals Inc  ACRX.OQ   ACRX.O  is expected
to show a rise in quarterly revenue when it reports  results on
November 15. 
* The Hayward, California-based company is expected to report  a
38.9% increase in revenue to $1.9 million from $1.37 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
​* Refinitiv's mean analyst estimate for AcelRx Pharmaceuticals
Inc is for a loss of 7 cents per share. For the same quarter
last year, the company reported a loss of 10 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for AcelRx
Pharmaceuticals Inc is $5​, about 84.1% above​ its last closing
price of $0.80. ​​​
This summary was machine generated November 12 at 16:03 GMT. 
All figures in US dollars  unless otherwise stated